ArticleHematology, transfusion and cell therapy

Part 3: Myelodysplastic syndromes-Treatment of low-risk patients without the 5q deletion.

Elvira Deolinda Rodrigues Pereira Velloso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.